2023 Q2 Form 10-Q Financial Statement

#000149315223016842 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $179.3K $385.1K
YoY Change 7.64% 1.57%
Cost Of Revenue $93.24K $6.310K $403.8K
YoY Change -76.71% -98.44% 35.72%
Gross Profit $86.08K -$6.310K -$18.71K
YoY Change -136.81% -66.27% -122.92%
Gross Profit Margin 48.0% -4.86%
Selling, General & Admin $2.857M $746.4K $2.856M
YoY Change 132.12% -73.86% -9.48%
% of Gross Profit 3319.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $68.27K $64.58K $164.5K
YoY Change -58.5% -60.75% 1505.07%
% of Gross Profit 79.31%
Operating Expenses $19.88M $817.3K $3.020M
YoY Change 1006.8% -72.94% -4.26%
Operating Profit -$19.70M -$817.3K -$3.039M
YoY Change 1108.95% -73.11% -1.11%
Interest Expense $43.72K $154.1K -$148.1K
YoY Change -81.98% -204.06% -33.93%
% of Operating Profit
Other Income/Expense, Net -$1.448M -$154.1K $49.60K
YoY Change 287.44% -410.65% -94.01%
Pretax Income -$21.15M -$971.4K -$3.096M
YoY Change 955.69% -68.62% 25.39%
Income Tax
% Of Pretax Income
Net Earnings -$21.10M -$971.4K -$3.089M
YoY Change 928.24% -68.56% 25.12%
Net Earnings / Revenue -11766.81% -802.13%
Basic Earnings Per Share -$0.19 -$0.09 -$0.34
Diluted Earnings Per Share -$0.19 -$0.09 -$327.7K
COMMON SHARES
Basic Shares Outstanding 167.8M shares 12.25M shares 9.428M shares
Diluted Shares Outstanding 112.2M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.551M $27.02K $1.122M
YoY Change 947.78% -97.59% -57.43%
Cash & Equivalents $8.551M $27.02K $1.122M
Short-Term Investments
Other Short-Term Assets $381.3K $4.748M $7.602M
YoY Change -92.09% -37.54% 2011.11%
Inventory $16.82K
Prepaid Expenses $381.3K $26.80K
Receivables $94.65K $0.00 $120.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $9.027M $4.775M $8.741M
YoY Change 60.12% -45.37% 164.81%
LONG-TERM ASSETS
Property, Plant & Equipment $7.350M $1.567M $4.293M
YoY Change 2.18% -63.49% 1527.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $150.0K $110.4K $18.20K
YoY Change 35.93% 506.32% -20.35%
Total Long-Term Assets $7.500M $1.678M $4.311M
YoY Change -0.38% -61.09% 938.01%
TOTAL ASSETS
Total Short-Term Assets $9.027M $4.775M $8.741M
Total Long-Term Assets $7.500M $1.678M $4.311M
Total Assets $16.53M $6.453M $13.05M
YoY Change 25.53% -50.56% 251.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.605M $3.566M $932.5K
YoY Change -15.06% 282.4% -72.58%
Accrued Expenses $19.33K $3.260M $2.471M
YoY Change -99.27% 31.93% 2173.02%
Deferred Revenue
YoY Change
Short-Term Debt $2.722M $4.994M $2.497M
YoY Change -11.78% 100.0% -0.13%
Long-Term Debt Due $2.722M $1.400M
YoY Change
Total Short-Term Liabilities $7.149M $13.71M $6.364M
YoY Change -11.75% 115.36% -3.32%
LONG-TERM LIABILITIES
Long-Term Debt $150.0K $149.9K $2.647M
YoY Change -94.33% -94.34% 2.6%
Other Long-Term Liabilities $1.236M $91.89K
YoY Change -12.8%
Total Long-Term Liabilities $1.386M $149.9K $2.739M
YoY Change -47.64% -94.53% 2.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.149M $13.71M $6.364M
Total Long-Term Liabilities $1.386M $149.9K $2.739M
Total Liabilities $8.535M $13.86M $9.103M
YoY Change -20.59% 52.21% -1.65%
SHAREHOLDERS EQUITY
Retained Earnings -$21.00M -$62.00M
YoY Change -59.96%
Common Stock $1.760M $1.224K
YoY Change 140556.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.992M -$7.402M $3.950M
YoY Change
Total Liabilities & Shareholders Equity $16.53M $6.453M $13.05M
YoY Change 25.53% -50.56% 251.23%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$21.10M -$971.4K -$3.089M
YoY Change 928.24% -68.56% 25.12%
Depreciation, Depletion And Amortization $68.27K $64.58K $164.5K
YoY Change -58.5% -60.75% 1505.07%
Cash From Operating Activities -$4.889M -$171.7K -$1.145M
YoY Change 1567.57% -85.0% -3.37%
INVESTING ACTIVITIES
Capital Expenditures $3.169M -$2.112M
YoY Change -199.55%
Acquisitions $15.17M
YoY Change
Other Investing Activities -$218.5K -$47.60K $707.8K
YoY Change -108.18% -106.72%
Cash From Investing Activities -$3.388M -$47.60K -$1.404M
YoY Change 560.86% -96.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.97M 886.0K
YoY Change 3293.44% -53.92%
NET CHANGE
Cash From Operating Activities -4.889M -$171.7K -1.145M
Cash From Investing Activities -3.388M -$47.60K -1.404M
Cash From Financing Activities 16.97M 886.0K
Net Change In Cash 8.691M -$219.3K -1.663M
YoY Change -2942.42% -86.81%
FREE CASH FLOW
Cash From Operating Activities -$4.889M -$171.7K -$1.145M
Capital Expenditures $3.169M -$2.112M
Free Cash Flow -$8.058M -$171.7K $966.8K
YoY Change -378.78% -117.76% -181.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Deferred Revenue Current
DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent
usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001162896
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 CRKR Receivable From Sale Of Investment Current
ReceivableFromSaleOfInvestmentCurrent
usd
CY2023Q1 CRKR Ppp Loan Forgiveness
PPPLoanForgiveness
usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
usd
CY2023Q1 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
CY2022Q1 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
CY2022Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
usd
CY2022Q1 CRKR Stock Issued During Period Conversion Of Series B Preferred Stock To Common
StockIssuedDuringPeriodConversionOfSeriesBPreferredStockToCommon
usd
CY2023Q1 CRKR Amortization Of Lease Right
AmortizationOfLeaseRight
usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
usd
CY2023Q1 CRKR Ppp Loan Forgiveness
PPPLoanForgiveness
usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022Q1 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2023Q1 CRKR Increase Decrease Cryptocurrency
IncreaseDecreaseCryptocurrency
usd
CY2023Q1 CRKR Increase Decrease In Discontinued Liabilities
IncreaseDecreaseInDiscontinuedLiabilities
usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2023Q1 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q1 CRKR Dividends On Preferred Stock
DividendsOnPreferredStock
usd
CY2023Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
CY2023Q1 CRKR Conversion Of Secured Convertible Debentures To Common Stock
ConversionOfSecuredConvertibleDebenturesToCommonStock
usd
CY2023Q1 CRKR Equipment Delivered During Period
EquipmentDeliveredDuringPeriod
usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
usd
CY2023Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
usd
CY2023Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Deferred Revenue Current
DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent
usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Other Current Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Other Current Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
CY2022Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
usd
CY2022Q1 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
usd
CY2022Q1 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
usd
CY2022Q1 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
usd
CY2022Q1 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
usd
CY2023Q1 CRKR Disposal Group Including Discontinued Operation Other Income And Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeAndExpense
usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Interest Income
DisposalGroupIncludingDiscontinuedOperationInterestIncome
usd
CY2022Q1 us-gaap Disposal Group Including Discontinued Operation Interest Income
DisposalGroupIncludingDiscontinuedOperationInterestIncome
usd
CY2023Q1 CRKR Disposal Group Including Discontinued Operationt Income Loss On Disposal Of Fixed Assets
DisposalGroupIncludingDiscontinuedOperationtIncomeLossOnDisposalOfFixedAssets
usd
CY2022Q1 CRKR Disposal Group Including Discontinued Operationt Income Loss On Disposal Of Fixed Assets
DisposalGroupIncludingDiscontinuedOperationtIncomeLossOnDisposalOfFixedAssets
usd
CY2023Q1 CRKR Disposal Group Including Discontinued Operation Other Income Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
usd
CY2023Q1 CRKR Disposal Group Including Discontinued Operation Income Loss
DisposalGroupIncludingDiscontinuedOperationIncomeLoss
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-33383
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Prairie Operating Co.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0357690
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8636 N. Classen Boulevard
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Oklahoma City
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
73114
CY2023Q1 dei City Area Code
CityAreaCode
(713)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
424-4247
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
167828942 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27020 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
246358 usd
CY2022Q4 CRKR Receivable From Sale Of Investment Current
ReceivableFromSaleOfInvestmentCurrent
90000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
26799 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
40702 usd
CY2023Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4721280 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4673680 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
4775099 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5050740 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
811792 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
747216 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1567431 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1632007 usd
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
110350 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
110350 usd
CY2023Q1 us-gaap Assets
Assets
6452880 usd
CY2022Q4 us-gaap Assets
Assets
6793097 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3565924 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3232855 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
3259997 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3055989 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1400000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1400000 usd
CY2023Q1 us-gaap Secured Debt Current
SecuredDebtCurrent
4993700 usd
CY2022Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
4993700 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
485712 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
485712 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13705333 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13168256 usd
CY2023Q1 us-gaap Loans Payable
LoansPayable
149900 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
149900 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
149900 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
149900 usd
CY2023Q1 us-gaap Liabilities
Liabilities
13855233 usd
CY2022Q4 us-gaap Liabilities
Liabilities
13318156 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12246036 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12246036 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12246036 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12246036 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1224 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1224 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54296425 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54202355 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61700030 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60728664 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-7402353 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6525059 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6452880 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6793097 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
385114 usd
CY2023Q1 CRKR Cryptocurrency Mining Costs
CryptocurrencyMiningCosts
6305 usd
CY2022Q1 CRKR Cryptocurrency Mining Costs
CryptocurrencyMiningCosts
386342 usd
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
17478 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
64576 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
164520 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
170120 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1923105 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
576289 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
932861 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
106105 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
817290 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
3530411 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-817290 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3145297 usd
CY2022Q1 CRKR Ppp Loan Forgiveness
PPPLoanForgiveness
197662 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
154076 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
148064 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-154076 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
49598 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-971366 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3095699 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-971366 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3095699 usd
CY2022Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
6604 usd
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
6604 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-971366 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3089095 usd
CY2023Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
95472 usd
CY2022Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
99510 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1066838 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3188605 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.09
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.34
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12246036 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9427905 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4197847 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
109383 usd
CY2022Q1 CRKR Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
900000 usd
CY2022Q1 CRKR Adjustments To Additional Paid In Capital Replacement Warrants Issued
AdjustmentsToAdditionalPaidInCapitalReplacementWarrantsIssued
1608000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
45000 usd
CY2022Q1 CRKR Stock Issued During Period Value Issuance Of Series Preferred Stock To Settle Compensation
StockIssuedDuringPeriodValueIssuanceOfSeriesPreferredStockToSettleCompensation
160720 usd
CY2022Q1 CRKR Stock Issued During Period Issuance Of Series B Preferred Stock To Settle Liabilities
StockIssuedDuringPeriodIssuanceOfSeriesBPreferredStockToSettleLiabilities
111459 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
6300 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-66763 usd
CY2022Q1 CRKR Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings1
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings1
-32837 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3089095 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3950014 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-6525059 usd
CY2023Q1 CRKR Stock Issued During Period Value Issuance Of Series Preferred Stock To Settle Compensation
StockIssuedDuringPeriodValueIssuanceOfSeriesPreferredStockToSettleCompensation
170120 usd
CY2023Q1 CRKR Stock Issued During Period Issuance Of Series B Preferred Stock To Settle Liabilities
StockIssuedDuringPeriodIssuanceOfSeriesBPreferredStockToSettleLiabilities
19424 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-75784 usd
CY2023Q1 CRKR Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings1
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings1
-19688 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-971366 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-7402353 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-971366 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3089095 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
64576 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
164520 usd
CY2022Q1 CRKR Amortization Of Lease Right
AmortizationOfLeaseRight
-148 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
170120 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1923105 usd
CY2022Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
106105 usd
CY2022Q1 CRKR Ppp Loan Forgiveness
PPPLoanForgiveness
197662 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-307 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-90000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-13903 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
56414 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1906 usd
CY2022Q1 CRKR Increase Decrease Cryptocurrency
IncreaseDecreaseCryptocurrency
336187 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
556501 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
446413 usd
CY2023Q1 CRKR Increase Decrease In Unpaid Dividends On Preferred Stock
IncreaseDecreaseInUnpaidDividendsOnPreferredStock
-95472 usd
CY2022Q1 CRKR Increase Decrease In Unpaid Dividends On Preferred Stock
IncreaseDecreaseInUnpaidDividendsOnPreferredStock
-99600 usd
CY2022Q1 CRKR Increase Decrease In Discontinued Liabilities
IncreaseDecreaseInDiscontinuedLiabilities
-8384 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-171738 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1145134 usd
CY2023Q1 CRKR Payments For Deposits On Mining Equipment
PaymentsForDepositsOnMiningEquipment
47600 usd
CY2022Q1 CRKR Payments For Deposits On Mining Equipment
PaymentsForDepositsOnMiningEquipment
-707810 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2111932 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47600 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1404122 usd
CY2022Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
900000 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
-14033 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
885967 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-219338 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1663289 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
246358 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2785188 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27020 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1121899 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
170120 usd
CY2022Q1 us-gaap Stock Issued1
StockIssued1
160720 usd
CY2023Q1 CRKR Issuance Of Series B Preferred Stock To Settle Accrued Liabilities
IssuanceOfSeriesBPreferredStockToSettleAccruedLiabilities
19424 usd
CY2022Q1 CRKR Issuance Of Series B Preferred Stock To Settle Accrued Liabilities
IssuanceOfSeriesBPreferredStockToSettleAccruedLiabilities
111459 usd
CY2023Q1 CRKR Dividends On Preferred Stock
DividendsOnPreferredStock
95472 usd
CY2022Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
239 usd
CY2022Q1 CRKR Conversion Of Secured Convertible Debentures To Common Stock
ConversionOfSecuredConvertibleDebenturesToCommonStock
6300 usd
CY2023Q1 CRKR Minors Description
MinorsDescription
we had 510 Bitmain S19J Pro miners with 51.0 Ph/s of hashing capacity and 270 Bitmain S19 miners with 24.3 Ph/s of hashing capacity.
CY2023Q1 CRKR Factors Affecting Profitability Description
FactorsAffectingProfitabilityDescription
(1) on November 28, 2012 at block 210,000; (2) on July 9, 2016 at block 420,000; and (3) on May 11, 2020 at block 630,000, when the reward was reduced to its current level of 6.25 Bitcoin per block. The next halving for the Bitcoin blockchain is anticipated to occur in March 2024 at block 840,000, when the reward will be reduced to 3.125 Bitcoin per block
CY2023Q1 CRKR Changes In Markets Price Of Bitcoin Description
ChangesInMarketsPriceOfBitcoinDescription
the market price of Bitcoin was $28,478, which reflects a decrease of approximately 31% since the beginning of 2022, and a decrease of approximately 58% from its all-time high of approximately $67,000.
CY2023Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
28478 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-971366 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3095699 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27020 usd
CY2023Q1 CRKR Working Capital Deficit
WorkingCapitalDeficit
-9000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
17300000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zhduvexjduba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b><i><span id="xdx_867_zaz3npl5Q6P">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These estimates and assumptions include estimates for reserves of uncollectible accounts, accruals for potential liabilities, assumptions made in valuing equity instruments issued for services or acquisitions, and realization of deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zgfMA7mEln9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b><i><span id="xdx_862_zMmNNJI1Lde2">Reclassification</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified to conform to current period presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_ztoKSZOQ4HMf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b><i><span id="xdx_861_zbDwNoUh93Gb">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_c20230331_zpoTAz3UqBod" title="FDIC insurance limit">250,000</span> insurance limit. The Company does not anticipate incurring any losses related to these credit risks.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
CY2023Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100089456 shares
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
7613230 usd
CY2022 CRKR Deposits On Equipment During Period
DepositsOnEquipmentDuringPeriod
2132730 usd
CY2022 CRKR Equipment Delivered During Period
EquipmentDeliveredDuringPeriod
-5072280 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4673680 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4673680 usd
CY2023Q1 CRKR Deposits On Equipment During Period
DepositsOnEquipmentDuringPeriod
47600 usd
CY2023Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4721280 usd
CY2023Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4721280 usd
CY2023Q1 CRKR Minors Description
MinorsDescription
we had 510 Bitmain S19J Pro miners with 51.0 Ph/s of hashing capacity and 270 Bitmain S19 miners with 24.3 Ph/s of hashing capacity.
CY2023Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2022Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
106105 usd
CY2023Q1 CRKR Cryptocurrency Miners Gross
CryptocurrencyMinersGross
2152970 usd
CY2022Q4 CRKR Cryptocurrency Miners Gross
CryptocurrencyMinersGross
2152970 usd
CY2023Q1 CRKR Mobile Data Center Gross
MobileDataCenterGross
219372 usd
CY2022Q4 CRKR Mobile Data Center Gross
MobileDataCenterGross
219372 usd
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
6881 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
6881 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2379223 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2379223 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
811792 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
747216 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1567431 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1632007 usd
CY2023Q1 us-gaap Depreciation
Depreciation
64576 usd
CY2022Q1 us-gaap Depreciation
Depreciation
164520 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
3259997 usd
CY2023Q1 us-gaap Secured Debt Current
SecuredDebtCurrent
4993700 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3055989 usd
CY2022Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
4993700 usd
CY2021Q3 CRKR Non Accountable Expense Reimbursement
NonAccountableExpenseReimbursement
200000 usd
CY2020Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
86466 shares
CY2020Q1 us-gaap Debt Instrument Description
DebtInstrumentDescription
The loans bear interest at an annual rate of one percent (1%), are due two (2) years from the date of issuance, and all payments are deferred for the first six (6) months of the loan. Any unforgiven balance of loan principal and accrued interest at the end of the six (6) month loan deferral period is amortized in equal monthly installments over the remaining 18-months of the loan term
CY2023Q1 us-gaap Loans Payable
LoansPayable
149900 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
149900 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
259250 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.25
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
259250 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.25
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
259250 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.25
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
259250 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.25
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y9M18D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
250000 shares
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.75
CY2022Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
600000 shares
CY2022Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
900000 usd
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
600000 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
21948266 shares
CY2023Q1 CRKR Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
21948266 shares
CRKR Reasonfor Exerciseof Warrant
ReasonforExerciseofWarrant
The Company can force the exercise of the warrants if the VWAP exceeds $3.75 per share per share for 20 consecutive trading days and the daily average trading volume of the Common Stock exceeds $100,000 in aggregate value for such period. The warrant holder may not be forced to exercise the warrant if such exercise would cause the holder’s beneficial ownership to exceed 4.9%
CY2020Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
We implemented a 1-for-20 reverse stock split of our outstanding shares of common stock that was effective on January 23, 2020. Unless otherwise noted, all share and related option, warrant, and convertible security information presented has been retroactively adjusted to reflect the reduced number of shares, and the increase in the share price which resulted from this action
CY2021Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3925050 usd
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2933340 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.50
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q4 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
3900000 usd
CY2023Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
15607371 shares
CY2023Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
3149280 shares
CY2022Q3 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
185167 shares
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
485712 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
485712 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
485712 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
485712 usd
CY2022Q1 CRKR Disposal Group Including Discontinued Operation Other Income And Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeAndExpense
6004 usd
CY2022Q1 CRKR Disposal Group Including Discontinued Operation Other Income Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
6004 usd
CY2022Q1 CRKR Disposal Group Including Discontinued Operation Income Loss
DisposalGroupIncludingDiscontinuedOperationIncomeLoss
6004 usd

Files In Submission

Name View Source Status
0001493152-23-016842-index-headers.html Edgar Link pending
0001493152-23-016842-index.html Edgar Link pending
0001493152-23-016842.txt Edgar Link pending
0001493152-23-016842-xbrl.zip Edgar Link pending
crkr-20230331.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
crkr-20230331_cal.xml Edgar Link unprocessable
crkr-20230331_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
crkr-20230331_lab.xml Edgar Link unprocessable
crkr-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable